Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Andersson, C. Kamby, M. Jensen, H. Mouridsen, B. Ejlertsen, P. Dombernowsky, C. Rose, S. Cold, M. Overgaard, J. Andersen, M. Kjaer (1999)
Tamoxifen in high-risk premenopausal women with primary breast cancer receiving adjuvant chemotherapy. Report from the Danish Breast Cancer co-operative Group DBCG 82B Trial.European journal of cancer, 35 12
C Hilliges, M Hsu, M Gallagher, M Stempel, M El-Tamer, E Brogi (2014)
Morphologic features and prognostic value of lymphovascular invasion in lymph node positive breast carcinomaLab Invest., 94
S. Darby, M. Ewertz, P. Mcgale, A. Bennet, U. Blom-Goldman, D. Brønnum, C. Correa, D. Cutter, G. Gagliardi, B. Gigante, M. Jensen, A. Nisbet, R. Peto, K. Rahimi, Carolyn Taylor, P. Hall (2013)
Risk of ischemic heart disease in women after radiotherapy for breast cancer.The New England journal of medicine, 368 11
E. Botteri, E. Botteri, O. Gentilini, N. Rotmensz, Paolo Veronesi, S. Ratini, C. Fraga-Guedes, A. Toesca, C. Sangalli, A. Castillo, M. Rietjens, G. Viale, G. Viale, Roberto Orecchia, A. Goldhirsch, Umberto Veronesi (2012)
Mastectomy without radiotherapy: outcome analysis after 10 years of follow-up in a single institutionBreast Cancer Research and Treatment, 134
R. Roychoudhuri, D. Robinson, V. Putcha, J. Cuzick, S. Darby, H. Møller (2007)
Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: a population-based studyBMC Cancer, 7
A. Recht, E. Comen, R. Fine, G. Fleming, P. Hardenbergh, A. Ho, C. Hudis, E. Hwang, J. Kirshner, M. Morrow, K. Salerno, G. Sledge, L. Solin, P. Spears, T. Whelan, M. Somerfield, S. Edge (2016)
Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34 36
S. Shirvani, I. Pan, T. Buchholz, Ya-ChenTina Shih, K. Hoffman, S. Giordano, Benjamin Smith (2011)
Impact of evidence‐based clinical guidelines on the adoption of postmastectomy radiation in older womenCancer, 117
Rita Abi-Raad, R. Boutrus, Rui Wang, A. Niemierko, Shannon Macdonald, Barbara Smith, A. Taghian (2009)
Patterns and risk factors of locoregional recurrence in T1-T2 node negative breast cancer patients treated with mastectomy: implications for postmastectomy radiotherapy.International journal of radiation oncology, biology, physics, 81 3
F. Killander, H. Anderson, S. Rydén, T. Möller, K. Aspegren, Jeanette Ceberg, Christina Danewid, P. Malmström (2007)
Radiotherapy and tamoxifen after mastectomy in postmenopausal women -- 20 year follow-up of the South Sweden Breast Cancer Group randomised trial SSBCG II:I.European journal of cancer, 43 14
P. Poortmans, S. Collette, C. Kirkove, E. Limbergen, V. Budach, H. Struikmans, L. Collette, A. Fourquet, P. Maingon, M. Valli, K. Winter, S. Marnitz, I. Barillot, L. Scandolaro, E. Vonk, C. Rodenhuis, H. Marsiglia, N. Weidner, G. Tienhoven, C. Glanzmann, A. Kuten, R. Arriagada, H. Bartelink, W. Bogaert (2015)
Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer.The New England journal of medicine, 373 4
M. Donker, G. Tienhoven, M. Straver, P. Meijnen, Cornelis Velde, Robert Mansel, L. Cataliotti, A. Westenberg, Jean Klinkenbijl, L. Orzalesi, Willem Bouma, H. Mijle, G. Nieuwenhuijzen, S. Veltkamp, L. Slaets, Nicole Duez, Peter Graaf, T. Dalen, Andreas Marinelli, H. Rijna, M. Snoj, N. Bundred, Jos Merkus, Y. Belkacemi, P. Petignat, D. Schinagl, C. Coens, Carlo Messina, J. Bogaerts, E. Rutgers (2014)
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.The Lancet. Oncology, 15 12
S. MacDonald, Rita Abi-Raad, M. El-Din, A. Niemierko, W. Kobayashi, J. McGrath, S. Goldberg, S. Powell, Barbara Smith, A. Taghian (2009)
Chest wall radiotherapy: middle ground for treatment of patients with one to three positive lymph nodes after mastectomy.International journal of radiation oncology, biology, physics, 75 5
A. Taghian, Jong-Hyeon Jeong, E. Mamounas, D. Parda, M. Deutsch, J. Costantino, N. Wolmark (2006)
Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 24
D. Cameron, M. Piccart-Gebhart, R. Gelber, M. Procter, A. Goldhirsch, E. Azambuja, G. Castro, M. Untch, I. Smith, L. Gianni, J. Baselga, N. Al-Sakaff, S. Lauer, E. McFadden, B. Leyland-Jones, R. Bell, M. Dowsett, C. Jackisch (2017)
11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trialThe Lancet, 389
D. Cowen, E. Gross, P. Rouannet, E. Teissier, S. Ellis, M. Resbeut, A., Tallet, V. Cowen, D. Azria, J. Hannoun-Levi (2010)
Immediate post-mastectomy breast reconstruction followed by radiotherapy: risk factors for complicationsBreast Cancer Research and Treatment, 121
E. Yıldırım, U. Berberoǧlu (2007)
Local recurrence in breast carcinoma patients with T(1-2) and 1-3 positive nodes: indications for radiotherapy.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 33 1
L. Warren, Cynthia Miller, N. Horick, Melissa Skolny, Lauren Jammallo, Betro Sadek, Mina Shenouda, J. O’Toole, S. MacDonald, M. Specht, A. Taghian (2014)
The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study.International journal of radiation oncology, biology, physics, 88 3
L. Frasier, S. Holden, T. Holden, J. Schumacher, G. Leverson, B. Anderson, C. Greenberg, H. Neuman (2016)
Temporal Trends in Postmastectomy Radiation Therapy and Breast Reconstruction Associated With Changes in National Comprehensive Cancer Network Guidelines.JAMA oncology, 2 1
(2012)
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
A. Mcbride, P. Allen, W. Woodward, Michelle Kim, H. Kuerer, E. Drinka, A. Sahin, E. Strom, A. Buzdar, V. Valero, G. Hortobagyi, K. Hunt, T. Buchholz (2014)
Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment.International journal of radiation oncology, biology, physics, 89 2
M. Piccart-Gebhart, M. Procter, B. Leyland-Jones, A. Goldhirsch, M. Untch, I. Smith, L. Gianni, J. Baselga, R. Bell, C. Jackisch, D. Cameron, M. Dowsett, C. Barrios, G. Steger, C. Huang, M. Andersson, M. Inbar, M. Lichinitser, I. Láng, U. Nitz, H. Iwata, C. Thomssen, C. Lohrisch, T. Suter, J. Rüschoff, T. Suto, V. Greatorex, C. Ward, C. Straehle, E. McFadden, M. Dolci, R. Gelber (2005)
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.The New England journal of medicine, 353 16
Y. Hamamoto, S. Ohsumi, K. Aogi, Syuichi Shinohara, N. Nakajima, M. Kataoka, S. Takashima (2014)
Are there high-risk subgroups for isolated locoregional failure in patients who had T1/2 breast cancer with one to three positive lymph nodes and received mastectomy without radiotherapy?Breast Cancer, 21
M. Overgaard, M. Jensen, J. Overgaard, P. Hansen, C. Rose, M. Andersson, C. Kamby, M. Kjaer, C. Gadeberg, B. Rasmussen, M. Blichert‐Toft, H. Mouridsen (1999)
Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trialThe Lancet, 353
R. Tendulkar, S. Rehman, M. Shukla, Chandana Reddy, H. Moore, G. Budd, J. Dietz, J. Crowe, R. Macklis (2012)
Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy.International journal of radiation oncology, biology, physics, 83 5
Po-Sheng Yang, Chi Chen, Meiping Liu, J. Jian, C. Horng, Meilin Liu, B. Yu, Ming‐Yuan Lee, C. Chi (2010)
Radiotherapy can decrease locoregional recurrence and increase survival in mastectomy patients with T1 to T2 breast cancer and one to three positive nodes with negative estrogen receptor and positive lymphovascular invasion status.International journal of radiation oncology, biology, physics, 77 2
E. Mușat, P. Poortmans, W. Bogaert, H. Struikmans, A. Fourquet, H. Bartelink, C. Kirkove, V. Budach, M. Piérart, L. Collette (2007)
Quality assurance in breast cancer: EORTC experiences in the phase III trial on irradiation of the internal mammary nodes.European journal of cancer, 43 4
C. Lu, H. Xu, X. Chen, Z. Tong, X. Liu, Y. Jia (2013)
Irradiation after surgery for breast cancer patients with primary tumours and one to three positive axillary lymph nodes: yes or no?Current oncology, 20 6
Eff ect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
R. Gopal (2016)
The Effect of Adjuvant Trastuzumab on Locoregional Recurrence of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated with Mastectomy: Lanning RM, Morrow M, Riaz N, et al (Memorial Sloan Kettering Cancer Ctr, New York) Ann Surg Oncol 22:2517-2525, 2015§Breast Diseases: A Year Book Quarterly, 27
A. Katz, E. Strom, T. Buchholz, H. Thames, Cynthia Smith, A. Jhingran, G. Hortobagyi, A. Buzdar, R. Theriault, E. Singletary, McNeese McNeese (2000)
Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 18 15
P. Truong, I. Olivotto, H. Kader, M. Panades, C. Speers, E. Berthelet (2005)
Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.International journal of radiation oncology, biology, physics, 61 5
J. Cuzick, I. Šestak, M. Baum, A. Buzdar, A. Howell, M. Dowsett, J. Forbes (2010)
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial.The Lancet. Oncology, 11 12
Ranjna Sharma, I. Bedrosian, A. Lucci, R. Hwang, Loren Rourke, W. Qiao, T. Buchholz, S. Kronowitz, S. Krishnamurthy, G. Babiera, A. González-Angulo, F. Meric-Bernstam, E. Mittendorf, K. Hunt, H. Kuerer (2010)
Present-Day Locoregional Control in Patients with T1 or T2 Breast Cancer with 0 and 1 to 3 Positive Lymph Nodes After Mastectomy Without RadiotherapyAnnals of Surgical Oncology, 17
B. Kelley, R. Ahmed, K. Kidwell, Jeffrey Kozlow, K. Chung, Adeyiza Momoh (2014)
A Systematic Review of Morbidity Associated with Autologous Breast Reconstruction Before and After Exposure to Radiotherapy: Are Current Practices Ideal?Annals of Surgical Oncology, 21
M. Overgaard, H. Nielsen, J. Overgaard (2007)
Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 82 3
M. Clarke, R. Collins, S. Darby, C. Davies, P. Elphinstone, V. Evans, J. Godwin, R. Gray, C. Hicks, S. James, E. Mackinnon, P. Mcgale, T. McHugh, R. Peto, Carolyn Taylor, Yaochen Wang (2005)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 366
T. Moo, Robert McMillan, Michele Lee, M. Stempel, S. Patil, A. Ho, M. El-Tamer (2013)
Selection Criteria for Postmastectomy Radiotherapy in T1–T2 Tumors with 1 to 3 Positive Lymph NodesAnnals of Surgical Oncology, 20
E. Romond, E. Perez, J. Bryant, V. Suman, C. Geyer, N. Davidson, E. Tan-chiu, S. Martino, S. Paik, P. Kaufman, S. Swain, T. Pisansky, L. Fehrenbacher, L. Kutteh, V. Vogel, D. Visscher, G. Yothers, R. Jenkins, A. Brown, S. Dakhil, E. Mamounas, W. Lingle, P. Klein, J. Ingle, N. Wolmark (2005)
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.The New England journal of medicine, 353 16
G. Gyenes, L. Rutqvist, A. Liedberg, T. Fornander (1998)
Long-term cardiac morbidity and mortality in a randomized trial of pre- and postoperative radiation therapy versus surgery alone in primary breast cancer.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 48 2
McGale P Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2014)
2127Lancet., 383
A. Recht, R. Gray, N. Davidson, B. Fowble, L. Solin, F. Cummings, G. Falkson, H. Falkson, S. Taylor, D. Tormey (1999)
Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 17 6
Ryan Lanning, M. Morrow, N. Riaz, H. McArthur, C. Dang, T. Moo, M. El-Tamer, K. Krause, C. Siu, M. Hsu, Zhigang Zhang, X. Pei, B. McCormick, S. Powell, A. Ho (2015)
The Effect of Adjuvant Trastuzumab on Locoregional Recurrence of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated with MastectomyAnnals of Surgical Oncology, 22
P. Poortmans, H. Struikmans, H. Bartelink (2015)
Regional Nodal Irradiation in Early-Stage Breast Cancer.The New England journal of medicine, 373 19
T. Grantzau, L. Mellemkjær, J. Overgaard (2013)
Second primary cancers after adjuvant radiotherapy in early breast cancer patients: a national population based study under the Danish Breast Cancer Cooperative Group (DBCG).Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 106 1
Ann Surg Oncol (2018) 25:1912–1920 https://doi.org/10.1245/s10434-018-6422-9 OR IG INA L A R TIC L E – BREA S T O NC OLOG Y Most Breast Cancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need Postmastectomy Radiotherapy 1 1 2 1 Shirin Muhsen, MD , Tracy-Ann Moo, MD , Sujata Patil, PhD , Michelle Stempel, MPH , Simon Powell, MD, 3 1 1 PhD , Monica Morrow, MD , and Mahmoud El-Tamer, MD 1 2 Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY ABSTRACT tumors (p = 0.0013), higher histologic grade (p = 0.029), Background/Objective. Guidelines concur that postmas- more positive LNs (p \ 0.0001), lymphovascular invasion tectomy radiation therapy (PMRT) in T1-2 tumors with one (LVI) (p \ 0.0001), extracapsular nodal extension to three positive (?) lymph nodes (LNs) decreases (p \ 0.0001), and macroscopic LN metastases locoregional recurrence (LRR) but advise limiting PMRT (p \ 0.0001). There was no difference in LRR, RFS, or OS to patients at highest risk to balance
Annals of Surgical Oncology – Springer Journals
Published: Mar 21, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.